drugset / Trial / NCT01203540

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

NCT01203540 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device. Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment. The patients will attend 4 visits.

Timeline

Start
2010-10
Primary completion
—
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetyl-aspartyl-glutamic acid Unknown — Other

Indications